Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma to the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT03515538
What this trial is testing

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

Who this might be right for
Oral Mucositis
EpicentRx, Inc. 53
Early research (Phase 1)Ended earlyNCT04152018
What this trial is testing

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Cancer+8 more
Pfizer 85
Testing effectiveness (Phase 2)Looking for participantsNCT06137378
What this trial is testing

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma Stage III+9 more
University of Leipzig 140
Very early researchEnded earlyNCT02402348
What this trial is testing

Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis

Who this might be right for
Cancer of Head and Neck
West Virginia University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT02131155
What this trial is testing

LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Who this might be right for
Head and Neck Neoplasms
Boehringer Ingelheim 36
Testing effectiveness (Phase 2)Looking for participantsNCT07195734
What this trial is testing

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04052204
What this trial is testing

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 3
Early research (Phase 1)Study completedNCT06549816
What this trial is testing

SGN-B6A in Chinese Participants With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more
Seagen, a wholly owned subsidiary of Pfizer 6
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT01856478
What this trial is testing

LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Who this might be right for
Head and Neck Neoplasms
Boehringer Ingelheim 340
Testing effectiveness (Phase 2)Study completedNCT01903018
What this trial is testing

Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Who this might be right for
Radiation Induced Mucositis in Head and Neck Cancer
Piramal Enterprises Limited 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT05312710
What this trial is testing

Safety and Efficacy of APG-157 in Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Oral CavitySquamous Cell Carcinoma of the Oropharynx
Aveta Biomics, Inc. 24
Early research (Phase 1)Study completedNCT04045496
What this trial is testing

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Jacobio Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT04523883
What this trial is testing

Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 316
Early research (Phase 1)Temporarily pausedNCT03970382
What this trial is testing

Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
PACT Pharma, Inc. 21
Large-scale testing (Phase 3)Ended earlyNCT00004227
What this trial is testing

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

Who this might be right for
Head and Neck Cancer
University of Alabama at Birmingham 32
Not applicableUnknownNCT05437380
What this trial is testing

Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC

Who this might be right for
Sentinel Lymph NodeHead and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 70
Testing effectiveness (Phase 2)Ended earlyNCT00272181
What this trial is testing

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more
Sesen Bio, Inc. 15
Next Page
52
180